J Mov Disord.  2017 Jan;10(1):29-34. 10.14802/jmd.16057.

Validation of the Korean Version of the Scale for Outcomes in Parkinson's Disease-Autonomic

Affiliations
  • 1Department of Neurology, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea.
  • 2Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul, Korea. neuronet@catholic.ac.kr
  • 3Department of Neurology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
  • 4Department of Neurology, Kyung Hee University College of Medicine, Seoul, Korea.
  • 5Department of Neurology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.
  • 6Department of Neurology, Dong-A University College of Medicine, Busan, Korea.
  • 7Department of Neurology and Neuroscience Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • 8Department of Neurology, Hallym University College of Medicine, Anyang, Korea.
  • 9Department of Neurology, Yeungnam University College of Medicine, Daegu, Korea.
  • 10Department of Neurology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.
  • 11Department of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • 12Department of Neurology, Parkinson/Alzheimer Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • 13Department of Neurology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • 14Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • 15Department of Neurology, College of Medicine, Gachon University, Incheon, Korea.
  • 16Department of Neurology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
  • 17Department of Neurology, Pusan National University Yangsan Hospital, Yangsan, Korea.
  • 18Department of Neurology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, College of Medicine, Seoul National University, Seoul, Korea.
  • 19Department of Neurology, Chungbuk National University School of Medicine, Chungbuk National University Hospital, Cheongju, Korea.
  • 20Department of Neurology, Ewha Womans University School of Medicine, Ewha Womans University Mokdong Hospital, Seoul, Korea.
  • 21Department of Neurology, Konkuk University Medical Center, Seoul, Korea.
  • 22Department of Neurology, Yonsei University Wonju College of Medicine, Wonju, Korea.
  • 23Department of Neurology, Bobath Memorial Hospital, Seongnam, Korea.
  • 24Department of Neurology, Soonchunhyang University Seoul Hospital, Soonchunhyang University School of Medicine, Seoul, Korea.
  • 25Department of Neurology, Chungnam National University School of Medicine, Chungnam National University Hospital, Daejeon, Korea.
  • 26Department of Neurology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
  • 27Department of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • 28Department of Neurology, Keimyung University School of Medicine, Daegu, Korea.
  • 29Department of Neurology, Soonchunhyang University Gumi Hospital, Soonchunhyang University School of Medicine, Gumi, Korea.
  • 30Department of Neurology, Hanyang University College of Medicine, Seoul, Korea.

Abstract


OBJECTIVE
Autonomic symptoms are commonly observed in patients with Parkinson's disease (PD) and often limit the activities of daily living. The Scale for Outcomes in Parkinson's disease-Autonomic (SCOPA-AUT) was developed to evaluate and quantify autonomic symptoms in PD. The goal of this study was to translate the original SCOPA-AUT, which was written in English, into Korean and to evaluate its reliability and validity for Korean PD patients.
METHODS
For the translation, the following processes were performed: forward translation, backward translation, expert review, pretest of the pre-final version and development of the final Korean version of SCOPA-AUT (K-SCOPA-AUT). In total, 127 patients with PD from 31 movement disorder clinics of university-affiliated hospitals in Korea were enrolled in this study. All patients were assessed using the K-SCOPA-AUT and other motor, non-motor, and quality of life scores. Test-retest reliability for the K-SCOPA-AUT was assessed over a time interval of 10−14 days.
RESULTS
The internal consistency and reliability of the K-SCOPA-AUT was 0.727 as measured by the mean Cronbach's α-coefficient. The test-retest correlation reliability was 0.859 by the Guttman split-half coefficient. The total K-SCOPA-AUT score showed a positive correlation with other non-motor symptoms [the Korean version of non-motor symptom scale (K-NMSS)], activities of daily living (Unified Parkinson's Disease Rating Scale part II) and quality of life [the Korean version of Parkinson's Disease Quality of Life 39 (K-PDQ39)].
CONCLUSION
The K-SCOPA-AUT had good reliability and validity for the assessment of autonomic dysfunction in Korean PD patients. Autonomic symptom severities were associated with many other motor and non-motor impairments and influenced quality of life.

Keyword

Autonomic; Parkinson's disease; Korean version; Scale for Outcomes in Parkinson's disease-Autonomic

MeSH Terms

Activities of Daily Living
Humans
Korea
Movement Disorders
Parkinson Disease
Quality of Life
Reproducibility of Results
Full Text Links
  • JMD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr